Sort
40,608 grants matching “prostate cancer”
Role of FOXO1 Inactivation in Prostate Tumorigenesis
$347,017Haojie Huang · Mayo Clinic Rochester · R01 · FY2019 · CA
Targeted Drug Delivery
$346,984Maurizio Pellecchia · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2013 · CA
Growth Factor Signaling in Prostate Development &Cancer
$346,980Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2001 · DK
Spectral CT metal artifact correction
$346,975Taly Gilat Schmidt · Marquette University · R01 · FY2020 · EB
Nitric Oxide as a Modifier of Oxidative Stress
$346,967David Wink · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA
Converting Cold to Hot Tumor Microenvironment in Prostate Cancer by Targeting Chromatin Effector
$346,934Xin Lu · University Of Notre Dame · R01 · FY2023 · CA
Growth Factor Signaling in Prostate Development &Cancer
$346,860Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2002 · DK
Telomeres, telomerase and chemotherapy: Bench to bedside
$346,857Jessie L.-S. Au · Optimum Therapeutics, Llc · R01 · FY2009 · CA
Discovery of Selective MAP2K4 Inhibitors to Target Metastasis
$346,802Karl A Scheidt · Northwestern University · R01 · FY2016 · CA
Discovery of Selective MAP2K4 Inhibitors to Target Metastasis
$346,802Karl A Scheidt · Northwestern University · R01 · FY2015 · CA
Discovery of Selective MAP2K4 Inhibitors to Target Metastasis
$346,802Karl A Scheidt · Northwestern University · R01 · FY2017 · CA
Cancer and Leukemia Group B: RPCI/SUNYAB
$346,791Roswell Park Cancer Institute Corp · U10 · FY2003 · CA
Dissecting and targeting a novel vulnerability in aggressive Rb1 and p53 doubly deficient prostate cancer
$346,789Wenliang Li · University Of Texas Hlth Sci Ctr Houston · R01 · FY2023 · CA
Systematic Genetic Characterization of African American Prostate Cancer
$346,750Levi Alexander Garraway · Dana-Farber Cancer Inst · U01 · FY2012 · CA
Molecular Determinants of Androgen Receptor Pharmacology
$346,733Donald P McDonnell · Duke University · R01 · FY2012 · CA
Human Endogenous retroviruses as potential early markers for Alzheimer's disease
$346,716Farah Bakhshian Rahmatpanah · University Of California-Irvine · R01 · FY2022 · CA
Project 2: Androgen deprivation as an immune modulating therapy in combination with targeted immunotherapy of prostate cancer
$346,701Douglas G McNeel · University Of Wisconsin-Madison · P50 · FY2023 · CA
Toward Selective Androgen Deprivation by Targeting Androgen Activation of SRF
$346,685Hannelore Heemers · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · CA
Toward Selective Androgen Deprivation by Targeting Androgen Activation of SRF
$346,685Hannelore Heemers · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · CA
Targeting Cell Cycle Alterations to Improve Treatment for Advanced Prostate Cancer
$346,682Karen E Knudsen · Thomas Jefferson University · R01 · FY2019 · CA
Tissue and Specimen Core
$346,674Robert Vessella · Fred Hutchinson Cancer Research Center · P50 · FY2008 · CA
Improving chemotherapy of castration-resistant prostate cancer.
$346,655Xiaoqi Liu · University Of Kentucky · R01 · FY2025 · CA
SPORE IN PROSTATE CANCER
$346,638University Of Michigan At Ann Arbor · P50 · FY2000 · CA
Phosphorylatable Monoclonal Antibodies for Tumor Therapy
$346,630Pbl Biomedical Laboratories · R44 · FY2003 · CA
Project 2: Arsenic as an Endocrine Disruptor
$346,603Joshua W Hamilton · Dartmouth College · P42 · FY2010 · ES